Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2013
06/19/2013CN101679504B Growth hormone fusion proteins
06/19/2013CN101678082B Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies
06/19/2013CN101659945B Clover xyloglucando transglycosylase (MtXET) and coding gene and applications thereof
06/19/2013CN101602793B Immunoregulatory polypeptide for preventing and/or treating rheumatoid arthritis and application thereof
06/19/2013CN101580538B WT1-origin HLA-DR-binding antigen peptide
06/19/2013CN101525669B Nuclear acid probe marked with quantum-dots composite sphere and preparation method and application thereof
06/19/2013CN101514232B RANKL-Fc fusion protein, preparation method and application thereof
06/19/2013CN101466835B Method for controlling the amount of gene product, and agent for controlling the amount of gene product
06/19/2013CN101460519B Human binding molecules having killing activity against staphylococci and uses thereof
06/19/2013CN101454449B 葡萄糖脱氢酶 Glucose dehydrogenase
06/19/2013CN101437944B Short interfering ribonucleic acid (siRNA) for oral administration
06/19/2013CN101432428B Recombinant human interferon-like proteins
06/19/2013CN101370831B Methods and compositions for treating allergic diseases
06/19/2013CN101316930B T-cell adhesion molecule and antibody directed against the molecule
06/19/2013CN101268191B Method for producing amino acids using micro-organisms
06/19/2013CN101213204B 丙型肝炎病毒核酸疫苗 Hepatitis C virus DNA vaccine
06/19/2013CN101128577B Recombinant microorganisms for increased production of organic acids
06/19/2013CN101006179B Method for modifying plant morphology, biochemistry and physiology comprising expression of cytokinin oxidase in the seeds
06/19/2013CN101001869B Carcinoembryonic antigen fusions and uses thereof
06/19/2013CA2762447A1 Fungal desaturase and elongase genes
06/18/2013US8467970 Function homology screening
06/18/2013US8466357 Maize variety inbred PH1D1W
06/18/2013US8466356 Maize variety inbred PH12KF
06/18/2013US8466353 Maize variety hybrid X8K846
06/18/2013US8466352 Inbred maize variety PH18WY
06/18/2013US8466351 Inbred maize variety PH18KJ
06/18/2013US8466350 Tomato line FIS 14-2100
06/18/2013US8466348 Soybean cultivar 84343415
06/18/2013US8466347 Brassica ogura restorer lines with shortened raphanus fragment (SRF)
06/18/2013US8466346 Corn event 5307
06/18/2013US8466345 Methods for plant transformation using spectinomycin selection
06/18/2013US8466344 Plant transcription factors
06/18/2013US8466343 Alfalfa variety 07W01CZ
06/18/2013US8466342 Early endosperm promoter and methods of use
06/18/2013US8466341 Maize 17KD oleosin seed-preferred regulatory element
06/18/2013US8466274 RNAi therapeutic for treatment of hepatitis C infection
06/18/2013US8466270 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing
06/18/2013US8466261 Therapeutic using a bispecific antibody
06/18/2013US8466258 Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis
06/18/2013US8466172 Stabilization of hypoxia inducible factor (HIF) alpha
06/18/2013US8466124 RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
06/18/2013US8466122 Trialkyl cationic lipids and methods of use thereof
06/18/2013US8466121 Method of selectively inhibiting the activity of ACAT1 in the treatment of Alzheimer's disease
06/18/2013US8466120 Oligomeric compounds and compositions for use in modulation of pri-miRNAs
06/18/2013US8466119 Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias
06/18/2013US8466118 Modulation of blood brain barrier protein expression
06/18/2013US8466117 Compositions and methods for modulating angiogenesis
06/18/2013US8466106 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
06/18/2013US8466091 Focused libraries of genetic packages
06/18/2013US8465975 Human late stage motor neuron progenitor cells produced from pluripotent stem cells
06/18/2013US8465974 Production of human late stage motor neuron progenitor cells
06/18/2013US8465971 Method for controlling biological function with mechanical vibration and device therefor
06/18/2013US8465965 Reagents and methods for cyanobacterial production of bioplastics and biomaterials
06/18/2013US8465962 Microorganism having enhanced L-valine productivity and method for producing L-valine using the same
06/18/2013US8465958 Polypeptides having endoglucanase activity and polynucleotides encoding same
06/18/2013US8465953 Ethanol production in non-recombinant hosts
06/18/2013US8465952 Microorganism producing L-methionine precursor and the method of producing L-methionine precursor using the microorganism
06/18/2013US8465949 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
06/18/2013US8465948 Long-acting veterinary polypeptides and methods of producing and administering same
06/18/2013US8465947 Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae
06/18/2013US8465945 Method for production and use of mite group 1 proteins
06/18/2013US8465942 Hydrolases, nucleic acids encoding them and methods for making and using them
06/18/2013US8465937 Methods for identifying B-clones which bind cell-surface antigens
06/18/2013US8465928 Canola event PV-BNGT04(RT73) and compositions and methods for detection thereof
06/18/2013US8465921 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
06/18/2013US8465914 Method and compositions involving microRNA
06/18/2013US8465750 Staphylococcus aureus proteins and nucleic acids
06/18/2013US8465748 Vaccine compositions and methods containing an immunogen derived from equine arteritis virus
06/18/2013US8465744 Method of treating inflammation by administering human IL-1B antibodies
06/18/2013US8465732 Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof
06/18/2013CA2635692C Human anti-il-23 antibodies, compositions, methods and uses
06/18/2013CA2603711C Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof
06/18/2013CA2592993C Method for detecting methylation in genes and method for examining neoplasm through detecting methylation in genes
06/18/2013CA2561245C Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
06/18/2013CA2452849C Method for monitoring and modulating protein folding
06/18/2013CA2446185C Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
06/18/2013CA2446087C Recombinant tumor specific antibody and use thereof
06/18/2013CA2440028C Rearranged squamous cell carcinoma antigen genes ii
06/18/2013CA2439042C Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts
06/18/2013CA2438273C Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis
06/18/2013CA2437318C Nucleotide sequence mediating male fertility and method of using same
06/18/2013CA2418144C Urocortin proteins and uses thereof
06/18/2013CA2415187C Dna vaccines encoding hiv accessory proteins
06/18/2013CA2345028C Regulation of embryonic transcription in plants
06/18/2013CA2278523C Rna binding protein and binding site useful for expression of recombinant molecules
06/13/2013WO2013086533A1 Neutralizing antibodies to hiv-1 and their use
06/13/2013WO2013086499A2 Transgenic plants having altered biomass composition
06/13/2013WO2013086494A1 Sucrose transporters and methods of generating pathogen-resistant plants
06/13/2013WO2013086489A1 Mirnas useful to reduce lung cancer tumorigenesis and chemotherapy resistance and related compositons and methods
06/13/2013WO2013086464A1 Markers associated with chronic lymphocytic leukemia prognosis and progression
06/13/2013WO2013086450A1 Diagnosis of lymphoid malignancies and minimal residual disease detection
06/13/2013WO2013086444A2 Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human lmna
06/13/2013WO2013086441A2 Oligonucleotide analogues targeting human lmna
06/13/2013WO2013086433A1 Sirna compositions and methods for inhibiting gene expression in tumor initiating cells of breast cancer
06/13/2013WO2013086430A1 Compositions and methods for purifying bax
06/13/2013WO2013086352A1 Prostate cancer associated circulating nucleic acid biomarkers
06/13/2013WO2013086331A1 High efficiency di-nucleotide cyclase
06/13/2013WO2013086228A1 Pegylated aspartyl-trna synthetase polypeptides
06/13/2013WO2013086219A1 Ribosomal promotors from b. subtilis for protein production in microorganisms
06/13/2013WO2013086216A1 Improved aspartyl-trna synthetases